Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04340141 |
Recruitment Status :
Recruiting
First Posted : April 9, 2020
Last Update Posted : April 9, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pancreatic Adenosquamous Carcinoma Resectable Pancreatic Adenocarcinoma Pancreatic Cancer | Drug: Oxaliplatin Drug: Irinotecan Hydrochloride Drug: Leucovorin Calcium Drug: Fluorouracil Procedure: Resection Other: Questionnaire Administration | Phase 3 |
PRIMARY OBJECTIVES:
I. To evaluate and compare overall survival (OS) in patients with resectable pancreatic adenocarcinoma treated with perioperative fluorouracil, irinotecan hydrochloride, leucovorin calcium and oxaliplatin (modified [m]FOLFIRINOX) and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
SECONDARY OBJECTIVES:
I. To evaluate and compare disease-free survival (DFS) in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
II. To evaluate and compare time to locoregional recurrence (TLR) in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
III. To evaluate and compare time to distant metastases (TDM) in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
IV. To evaluate and compare the R0 resection rate in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
V. To evaluate and compare rate of unresectability in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
VI. To evaluate rate of pathologic complete response in patients randomized to the perioperative therapy arm.
VII. To evaluate and compare mFOLFIRINOX dose intensity delivered and number of cycles received in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
VIII. To evaluate and compare adverse event profile in patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
IX. To compare physical functioning, nausea/vomiting, and diarrhea, as measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Core 30 (QLQ-C30) between patients with resectable pancreatic adenocarcinoma treated with perioperative mFOLFIRINOX and surgery versus up-front surgery followed by adjuvant mFOLFIRINOX.
X. To prospectively assess the influence of diet, body mass index, weight loss, physical activity, and other lifestyle habits on the disease-free survival and overall survival among patients with localized pancreatic cancers.
XI. To assess the influence of diet, obesity, physical activity, and other lifestyle habits on the risk of toxicity associated with chemotherapy.
XII. To evaluate the ability of computed tomography (CT)-based radiomics in distinguishing post-neoadjuvant chemotherapy (NAC) fibrosis from viable tumor in patients randomized to the perioperative therapy arm.
XIII. To determine whether CT-based radiomics retrieved from baseline examination may act as non-invasive predictors of survival outcome in patients randomized to the adjuvant therapy arm.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive oxaliplatin intravenously (IV) over 2 hours, irinotecan hydrochloride IV over 90 minutes, and leucovorin calcium over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1-3. Treatment repeats every 14 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Within 2-8 weeks of completing neoadjuvant chemotherapy, patients undergo surgical resection. Patients then receive oxaliplatin IV over 2 hours, irinotecan hydrochloride IV over 90 minutes, and leucovorin calcium over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1-3. Treatment repeats every 14 days for 4 cycles in the absence of disease progression or unacceptable toxicity.
ARM II: Patients undergo surgical resection. Beginning 3-12 weeks after surgery, patients then receive oxaliplatin IV over 2 hours, irinotecan hydrochloride IV over 90 minutes, and leucovorin calcium over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1-3. Treatment repeats every 14 days for 12 cycles in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up for 6 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 352 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer |
Actual Study Start Date : | July 1, 2020 |
Estimated Primary Completion Date : | January 2026 |
Estimated Study Completion Date : | November 2030 |
Arm | Intervention/treatment |
---|---|
Experimental: Arm I (perioperative chemotherapy, surgery)
Patients receive oxaliplatin intravenously (IV) over 2 hours, irinotecan hydrochloride IV over 90 minutes, and leucovorin calcium over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1-3. Treatment repeats every 14 days for 8 cycles in the absence of disease progression or unacceptable toxicity. Within 2-8 weeks of completing neoadjuvant chemotherapy, patients undergo surgical resection. Patients then receive oxaliplatin IV over 2 hours, irinotecan hydrochloride IV over 90 minutes, and leucovorin calcium over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1-3. Treatment repeats every 14 days for 4 cycles in the absence of disease progression or unacceptable toxicity.
|
Drug: Oxaliplatin
Given IV Drug: Irinotecan Hydrochloride Given IV Drug: Leucovorin Calcium Given IV Drug: Fluorouracil Given IV Procedure: Resection Undergo surgical resection Other: Questionnaire Administration Ancillary studies |
Active Comparator: Arm II (surgery, adjuvant chemotherapy)
Patients undergo surgical resection. Beginning 3-12 weeks after surgery, patients then receive oxaliplatin IV over 2 hours, irinotecan hydrochloride IV over 90 minutes, and leucovorin calcium over 2 hours on day 1, and fluorouracil IV over 46-48 hours on days 1-3. Treatment repeats every 14 days for 12 cycles in the absence of disease progression or unacceptable toxicity.
|
Drug: Oxaliplatin
Given IV Drug: Irinotecan Hydrochloride Given IV Drug: Leucovorin Calcium Given IV Drug: Fluorouracil Given IV Procedure: Resection Undergo surgical resection Other: Questionnaire Administration Ancillary studies |
- Overall survival (OS) [ Time Frame: Time between randomization and death from any cause, assessed up to 6 years. ]Overall survival is defined as the time from randomization to death due to any cause. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator. The treatment arms will be compared using a stratified Cox regression model, and hazard ratios from each arm will be estimated.
- Disease-free survival (DFS) [ Time Frame: Time between randomization and progression prior to surgery, metastases detected during surgery, recurrence (locoregional and/or distant) after resection, and death due to all causes, assessed up to 6 years. ]Disease-free survival (DFS) is defined as the time from randomization to the date of progression prior to surgery, metastases detected during surgery, recurrence (locoregional and/or distant) after resection, and death due to all causes, whichever occurs first. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator.
- Time to locoregional recurrence (TLR) [ Time Frame: Time between randomization and locoregional recurrence after resection, assessed up to 6 years. ]Time to locoregional recurrence (TLR) is defined as the time from randomization to the date of locoregional recurrence after resection. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator.
- Time to distant metastases (TDM) [ Time Frame: Time between randomization and metastases prior to surgery, metastases detected during surgery, or distant recurrence after resection, assessed up to 6 years. ]Time to distant metastases (TDM) is defined as the time from randomization to the date of metastases prior to surgery, metastases detected during surgery, or distant recurrence after resection. The median and 95% confidence intervals are estimated using the Kaplan-Meier estimator.
- R0 resection rate [ Time Frame: At time of surgery. ]The rate (percentage) of patients with negative resection margins after undergoing surgery.
- Rate of unresectability [ Time Frame: At time of surgery or planned time of surgery. ]The rate (percentage) of patients who cannot undergo surgery due to adverse events, progressive disease, death, poor performance, or patient/physician decision, are deemed unresectable before surgery, or resection was not performed during surgery.
- Pathologic complete response (pCR) rate [ Time Frame: At time of surgery. ]The rate (percentage) of patients who achieve a pathologic complete response (pCR) confirmed by histopathologic review of the surgical specimen.
- Incidence of adverse events (AEs), assessed using National Cancer Institute (NCI) common terminology criteria for adverse events (CTCAE) version 5.0 (v5.0) [ Time Frame: Up to 2 years. ]The maximum grade for each type of adverse event will be recorded for each patient, and frequency tables will be reviewed to determine adverse event patterns within treatment arms and during the following three time points: during perioperative chemotherapy, surgical complications during surgery and post-operative period for 30 days, and during adjuvant chemotherapy.
- Fluorouracil, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin (modified [m]FOLFIRINOX) dose intensity delivered [ Time Frame: 8 months ]Dose intensity is defined as the percentage of total cumulative dose the patient received divided by the total dose planned per protocol times 100.
- Fluorouracil, irinotecan hydrochloride, leucovorin calcium and oxaliplatin (modified [m]FOLFIRINOX) number of cycles received [ Time Frame: 8 months ]The number of cycles received is defined as the total number of cycles that the participant received at least one dose of any agent in mFOLFIRINOX.
- Quality of life as assessed by the physical functioning, nausea/vomiting, and diarrhea subscales in the Quality of Life Questionnaire-Core 30 (QLQ-C30) [ Time Frame: 8 weeks ]Quality of Life Questionnaire-Core 30 (QLQ-C30) is a 30-item questionnaire to assess the overall quality of life in cancer patients. QLQ-C30 includes functional scales (physical, role, cognitive, emotional, and social), global health status, symptom scales (fatigue, pain, nausea/vomiting), and other (dyspnoea, appetite loss, insomnia, constipation/diarrhea, and financial difficulties). Most questions used 4-point scale (1 'Not at All' to 4 'Very Much'); 2 questions used 7-point scale (1 'Very Poor' to 7 'Excellent'). Scores are averaged, and transformed to 0-100 scale; higher score=better level of physical functioning, greater occurrence of nausea/vomiting, and greater occurrence of diarrhea.
- Influence of diet, body mass index, weight loss, physical activity, and other lifestyle habits on overall survival [ Time Frame: Time between randomization and death from any cause, assessed up to 6 years. ]Multivariate Cox proportional hazards models will be fit for overall survival (OS) endpoint (defined above) with covariates corresponding to baseline diet and lifestyle questionnaire responses and hazard ratios and 95% confidence intervals will be reported.
- Influence of diet, body mass index, weight loss, physical activity, and other lifestyle habits on disease-free survival (DFS) [ Time Frame: Time between randomization and progression prior to surgery, metastases detected during surgery, recurrence (locoregional and/or distant) after resection, and death due to all causes, assessed up to 6 years. ]Multivariate Cox proportional hazards models will be fit for disease-free survival (DFS) endpoint (defined above) with covariates corresponding to baseline diet and lifestyle questionnaire responses and hazard ratios and 95% confidence intervals will be reported.
- Influence of diet, body mass index, weight loss, physical activity, and other lifestyle habits on the risk of grade 3+ adverse event associated with chemotherapy [ Time Frame: Up to 2 years. ]Multivariate Logistic models will be fit for the binary endpoint of grade 3+ adverse event (patient experiences at least one grade 3 or higher adverse event during treatment)
- The ability of computed tomography (CT)-based radiomics to distinguish post-neoadjuvant chemotherapy (NAC) fibrosis from viable tumor as measured by comparison to histological evaluation [ Time Frame: At time of surgery. ]Comparison between computed tomography (CT)-based radiomics and histological tumor fibrosis proportions will be measured using Spearman's rank correlation coefficient.
- Computed tomography (CT)-based radiomics as non-invasive predictors of overall survival [ Time Frame: Time between randomization and death from any cause, assessed up to 6 years. ]Multivariate Cox proportional hazards model will be fit for overall survival (OS) endpoint (defined above) with covariates chosen from all available radiomics features using the least absolute shrinkage and selection operator (LASSO) method with 10-fold cross-validation (CV) and additionally adjusted for clinically important confounders. After the final model is selected the area under the receiver operating characteristic curve (AUC) will be reported to indicate the prediction performance of the radiomics model.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
PRE-REGISTRATION:
- Pathology: Histologic or cytologic proof of pancreatic adenocarcinoma or adenosquamous carcinoma
- TNM Stage: Tx-4, N0-1, M0 (M0 disease does not include spread to distant lymph nodes and organs)
-
Resectable Primary Tumor: Local radiographic reading must be consistent with resectable disease defined as the following on 1) arterial and venous phase contrast-enhanced abdominal/pelvic CT scan or abdominal/pelvic magnetic resonance imaging (MRI) scan and 2) chest CT:
- No involvement or abutment of the celiac artery, common hepatic artery, superior mesenteric artery, or replaced right hepatic artery (if applicable)
- Less than 180 degree interface between tumor and vessel wall of the portal vein or superior mesenteric vein, and patent portal vein/splenic vein confluence
- No evidence of metastatic disease
- Measurable disease or non-measurable disease o Non-measurable disease is defined as cytologic or histologic confirmation of adenocarcinoma of adenosquamous carcinoma by fine needle aspiration or core-biopsy of the pancreas without measurable disease by radiographic imaging
REGISTRATION:
- Confirmation of resectable disease by real-time central imaging review by the Alliance Imaging Core Lab at Imaging and Radiation Oncology Core (IROC) Ohio
- Determined to be appropriate candidate for curative-intent pancreatectomy by surgeon intending to perform the resection
- No prior radiation therapy, chemotherapy, targeted therapy, investigational therapy, or surgery for pancreatic cancer
- Not pregnant and not nursing, because this study involves an agent that has known genotoxic, mutagenic, and teratogenic effects.
- Therefore, for women of childbearing potential only, a negative pregnancy test done =< 14 days prior to registration is required
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Total Neuropathy Score < 2
- Absolute neutrophil count (ANC) >= 1,500/uL
- Platelet count >= 100,000/uL
- Total bilirubin =< 1.5 x upper limit of normal (ULN) (If obstructive jaundice is present, then biliary drainage must be initiated and total bilirubin =< 3.0)
- Creatinine =< 1.5 x ULN OR calculated (Calc.) creatinine clearance >= 30 mL/min (Calculated using the Cockcroft-Gault equation)
- No known Gilbert's Syndrome or known homozygosity for UGAT1A1*28 polymorphism
- No comorbid conditions that would prohibit curative-intent pancreatectomy
- Chronic concomitant treatment with strong inhibitors of CYP3A4 is not allowed on this study. Patients on strong CYP3A4 inhibitors must discontinue the drug prior to registration
- Chronic concomitant treatment with strong inducers of CYP3A4 is not allowed on this study. Patients on strong CYP3A4 inducers must discontinue the drug prior to registration
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04340141
Contact: Cristina R. Ferrone, MD | 617-643-6189 | cferrone@mgh.harvard.edu |
United States, Alabama | |
University of Alabama at Birmingham Cancer Center | Active, not recruiting |
Birmingham, Alabama, United States, 35233 | |
Thomas Hospital | Recruiting |
Fairhope, Alabama, United States, 36532 | |
Contact: Site Public Contact 251-435-4584 | |
Principal Investigator: Prajwol Pathak | |
Mobile Infirmary Medical Center | Recruiting |
Mobile, Alabama, United States, 36607 | |
Contact: Site Public Contact 251-435-3942 | |
Principal Investigator: Prajwol Pathak | |
University of South Alabama Mitchell Cancer Institute | Recruiting |
Mobile, Alabama, United States, 36688 | |
Contact: Site Public Contact 251-445-9870 pfrancisco@usouthal.edu | |
Principal Investigator: Brian Persing | |
United States, Alaska | |
Anchorage Associates in Radiation Medicine | Suspended |
Anchorage, Alaska, United States, 98508 | |
Alaska Breast Care and Surgery LLC | Suspended |
Anchorage, Alaska, United States, 99508 | |
Alaska Oncology and Hematology LLC | Suspended |
Anchorage, Alaska, United States, 99508 | |
Alaska Women's Cancer Care | Suspended |
Anchorage, Alaska, United States, 99508 | |
Anchorage Oncology Centre | Suspended |
Anchorage, Alaska, United States, 99508 | |
Katmai Oncology Group | Suspended |
Anchorage, Alaska, United States, 99508 | |
Providence Alaska Medical Center | Suspended |
Anchorage, Alaska, United States, 99508 | |
United States, Arizona | |
Banner University Medical Center - Tucson | Active, not recruiting |
Tucson, Arizona, United States, 85719 | |
University of Arizona Cancer Center-North Campus | Active, not recruiting |
Tucson, Arizona, United States, 85719 | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Suspended |
Fort Smith, Arkansas, United States, 72903 | |
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro | Recruiting |
Jonesboro, Arkansas, United States, 72401 | |
Contact: Site Public Contact 870-936-7066 Emily.Carvell@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
University of Arkansas for Medical Sciences | Active, not recruiting |
Little Rock, Arkansas, United States, 72205 | |
United States, California | |
Kaiser Permanente-Deer Valley Medical Center | Recruiting |
Antioch, California, United States, 94531 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Sutter Cancer Centers Radiation Oncology Services-Auburn | Active, not recruiting |
Auburn, California, United States, 95603 | |
Alta Bates Summit Medical Center-Herrick Campus | Active, not recruiting |
Berkeley, California, United States, 94704 | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Suspended |
Burbank, California, United States, 91505 | |
Mills-Peninsula Medical Center | Active, not recruiting |
Burlingame, California, United States, 94010 | |
Sutter Cancer Centers Radiation Oncology Services-Cameron Park | Active, not recruiting |
Cameron Park, California, United States, 95682 | |
Community Cancer Institute | Active, not recruiting |
Clovis, California, United States, 93611 | |
Kaiser Permanente Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Fresno | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
UC San Diego Moores Cancer Center | Recruiting |
La Jolla, California, United States, 92093 | |
Contact: Site Public Contact 858-822-5354 cancercto@ucsd.edu | |
Principal Investigator: Andrew M. Lowy | |
Los Angeles General Medical Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 uscnorrisinfo@med.usc.edu | |
Principal Investigator: Sandra D. Algaze | |
USC / Norris Comprehensive Cancer Center | Recruiting |
Los Angeles, California, United States, 90033 | |
Contact: Site Public Contact 323-865-0451 | |
Principal Investigator: Sandra D. Algaze | |
Cedars Sinai Medical Center | Recruiting |
Los Angeles, California, United States, 90048 | |
Contact: Site Public Contact 310-423-8965 | |
Principal Investigator: Arsen Osipov | |
Memorial Medical Center | Active, not recruiting |
Modesto, California, United States, 95355 | |
Kaiser Permanente-Modesto | Recruiting |
Modesto, California, United States, 95356 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Palo Alto Medical Foundation-Camino Division | Active, not recruiting |
Mountain View, California, United States, 94040 | |
Kaiser Permanente-Oakland | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Saint Joseph Hospital - Orange | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 714-734-6220 | |
Principal Investigator: Timothy E. Byun | |
UC Irvine Health/Chao Family Comprehensive Cancer Center | Recruiting |
Orange, California, United States, 92868 | |
Contact: Site Public Contact 877-827-8839 ucstudy@uci.edu | |
Principal Investigator: Jennifer B. Valerin | |
Palo Alto Medical Foundation Health Care | Active, not recruiting |
Palo Alto, California, United States, 94301 | |
Stanford Cancer Institute Palo Alto | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 650-498-7061 ccto-office@stanford.edu | |
Principal Investigator: George Poultsides | |
Kaiser Permanente-Redwood City | Recruiting |
Redwood City, California, United States, 94063 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Richmond | Recruiting |
Richmond, California, United States, 94801 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Sutter Cancer Centers Radiation Oncology Services-Roseville | Active, not recruiting |
Roseville, California, United States, 95661 | |
Sutter Roseville Medical Center | Active, not recruiting |
Roseville, California, United States, 95661 | |
Kaiser Permanente Downtown Commons | Recruiting |
Sacramento, California, United States, 95814 | |
Contact: Site Public Contact 877-642-4691 kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Sutter Medical Center Sacramento | Active, not recruiting |
Sacramento, California, United States, 95816 | |
University of California Davis Comprehensive Cancer Center | Active, not recruiting |
Sacramento, California, United States, 95817 | |
Kaiser Permanente-South Sacramento | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
UC San Diego Medical Center - Hillcrest | Recruiting |
San Diego, California, United States, 92103 | |
Contact: Site Public Contact rhabbaba@health.ucsd.edu | |
Principal Investigator: Andrew M. Lowy | |
California Pacific Medical Center-Pacific Campus | Active, not recruiting |
San Francisco, California, United States, 94115 | |
Kaiser Permanente-San Francisco | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
UCSF Medical Center-Mission Bay | Recruiting |
San Francisco, California, United States, 94158 | |
Contact: Site Public Contact 877-827-3222 cancertrials@ucsf.edu | |
Principal Investigator: Andrew H. Ko | |
Kaiser Permanente-Santa Teresa-San Jose | Recruiting |
San Jose, California, United States, 95119 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente San Leandro | Recruiting |
San Leandro, California, United States, 94577 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Mills Health Center | Active, not recruiting |
San Mateo, California, United States, 94401 | |
Kaiser San Rafael-Gallinas | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente Medical Center - Santa Clara | Recruiting |
Santa Clara, California, United States, 95051 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Santa Rosa | Recruiting |
Santa Rosa, California, United States, 95403 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-South San Francisco | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Stockton | Recruiting |
Stockton, California, United States, 95210 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Palo Alto Medical Foundation-Sunnyvale | Active, not recruiting |
Sunnyvale, California, United States, 94086 | |
Sutter Cancer Centers Radiation Oncology Services-Vacaville | Suspended |
Vacaville, California, United States, 95687 | |
Kaiser Permanente Medical Center-Vacaville | Recruiting |
Vacaville, California, United States, 95688 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Vallejo | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Sutter Solano Medical Center/Cancer Center | Active, not recruiting |
Vallejo, California, United States, 94589 | |
Kaiser Permanente-Walnut Creek | Recruiting |
Walnut Creek, California, United States, 94596 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
United States, Colorado | |
Porter Adventist Hospital | Active, not recruiting |
Denver, Colorado, United States, 80210 | |
United States, Connecticut | |
Danbury Hospital | Recruiting |
Danbury, Connecticut, United States, 06810 | |
Contact: Site Public Contact 203-739-8074 | |
Principal Investigator: Richard C. Frank | |
Smilow Cancer Hospital-Derby Care Center | Recruiting |
Derby, Connecticut, United States, 06418 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital Care Center-Fairfield | Recruiting |
Fairfield, Connecticut, United States, 06824 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital Care Center at Glastonbury | Recruiting |
Glastonbury, Connecticut, United States, 06033 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital Care Center at Greenwich | Recruiting |
Greenwich, Connecticut, United States, 06830 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital Care Center - Guilford | Recruiting |
Guilford, Connecticut, United States, 06437 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Hartford Hospital | Recruiting |
Hartford, Connecticut, United States, 06102 | |
Contact: Site Public Contact 860-545-5363 | |
Principal Investigator: Jaykumar T. Thumar | |
Smilow Cancer Hospital Care Center at Saint Francis | Recruiting |
Hartford, Connecticut, United States, 06105 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Midstate Medical Center | Recruiting |
Meriden, Connecticut, United States, 06451 | |
Contact: Site Public Contact 866-662-5678 | |
Principal Investigator: Jaykumar T. Thumar | |
The Hospital of Central Connecticut | Recruiting |
New Britain, Connecticut, United States, 06050 | |
Contact: Site Public Contact 860-224-5660 | |
Principal Investigator: Jaykumar T. Thumar | |
Yale University | Recruiting |
New Haven, Connecticut, United States, 06520 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Yale-New Haven Hospital North Haven Medical Center | Recruiting |
North Haven, Connecticut, United States, 06473 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Norwalk Hospital | Recruiting |
Norwalk, Connecticut, United States, 06856 | |
Contact: Site Public Contact 203-852-2996 jennifer.long@norwalkhealth.org | |
Principal Investigator: Richard C. Frank | |
Smilow Cancer Hospital-Orange Care Center | Recruiting |
Orange, Connecticut, United States, 06477 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital-Torrington Care Center | Recruiting |
Torrington, Connecticut, United States, 06790 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital Care Center-Trumbull | Recruiting |
Trumbull, Connecticut, United States, 06611 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital-Waterbury Care Center | Recruiting |
Waterbury, Connecticut, United States, 06708 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
Smilow Cancer Hospital Care Center - Waterford | Recruiting |
Waterford, Connecticut, United States, 06385 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
United States, District of Columbia | |
MedStar Georgetown University Hospital | Active, not recruiting |
Washington, District of Columbia, United States, 20007 | |
Sibley Memorial Hospital | Recruiting |
Washington, District of Columbia, United States, 20016 | |
Contact: Site Public Contact 202-243-2373 jquiver1@jhmi.edu | |
Principal Investigator: Michael J. Pishvaian | |
United States, Florida | |
AdventHealth Altamonte | Active, not recruiting |
Altamonte Springs, Florida, United States, 32701 | |
Mount Sinai Comprehensive Cancer Center at Aventura | Suspended |
Aventura, Florida, United States, 33180 | |
UM Sylvester Comprehensive Cancer Center at Coral Gables | Recruiting |
Coral Gables, Florida, United States, 33146 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Nipun B. Merchant | |
UM Sylvester Comprehensive Cancer Center at Deerfield Beach | Recruiting |
Deerfield Beach, Florida, United States, 33442 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Nipun B. Merchant | |
Regional Cancer Center-Lee Memorial Health System | Recruiting |
Fort Myers, Florida, United States, 33905 | |
Contact: Site Public Contact 773-702-9171 protocols@AllianceNCTN.org | |
Principal Investigator: Paul M. Bloomston | |
Lakeland Regional Health Hollis Cancer Center | Suspended |
Lakeland, Florida, United States, 33805 | |
Mount Sinai Medical Center | Recruiting |
Miami Beach, Florida, United States, 33140 | |
Contact: Site Public Contact 305-674-2625 yenrique@msmc.com | |
Principal Investigator: Mike Cusnir | |
University of Miami Miller School of Medicine-Sylvester Cancer Center | Active, not recruiting |
Miami, Florida, United States, 33136 | |
UM Sylvester Comprehensive Cancer Center at Kendall | Recruiting |
Miami, Florida, United States, 33176 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Nipun B. Merchant | |
AdventHealth Orlando | Active, not recruiting |
Orlando, Florida, United States, 32803 | |
UM Sylvester Comprehensive Cancer Center at Plantation | Recruiting |
Plantation, Florida, United States, 33324 | |
Contact: Site Public Contact 305-243-2647 | |
Principal Investigator: Nipun B. Merchant | |
Cleveland Clinic-Weston | Recruiting |
Weston, Florida, United States, 33331 | |
Contact: Site Public Contact 954-659-5705 CancerAnswer@ccf.org | |
Principal Investigator: Alok A. Khorana | |
United States, Georgia | |
Phoebe Putney Memorial Hospital | Recruiting |
Albany, Georgia, United States, 31701 | |
Contact: Site Public Contact 229-312-0405 ga_cares@augusta.edu | |
Principal Investigator: Sharad A. Ghamande | |
Augusta University Medical Center | Active, not recruiting |
Augusta, Georgia, United States, 30912 | |
United States, Hawaii | |
Queen's Medical Center | Active, not recruiting |
Honolulu, Hawaii, United States, 96813 | |
Kaiser Permanente Moanalua Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96819 | |
Contact: Site Public Contact 808-432-5195 shelley.a.clark@kp.org | |
Principal Investigator: Tatjana Kolevska | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Active, not recruiting |
Boise, Idaho, United States, 83706 | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Caldwell | Active, not recruiting |
Caldwell, Idaho, United States, 83605 | |
Kootenai Health - Coeur d'Alene | Active, not recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Idaho Urologic Institute-Meridian | Active, not recruiting |
Meridian, Idaho, United States, 83642 | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Nampa | Active, not recruiting |
Nampa, Idaho, United States, 83687 | |
Kootenai Clinic Cancer Services - Post Falls | Active, not recruiting |
Post Falls, Idaho, United States, 83854 | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Rush - Copley Medical Center | Suspended |
Aurora, Illinois, United States, 60504 | |
Illinois CancerCare-Bloomington | Suspended |
Bloomington, Illinois, United States, 61704 | |
Illinois CancerCare-Canton | Suspended |
Canton, Illinois, United States, 61520 | |
Memorial Hospital of Carbondale | Suspended |
Carbondale, Illinois, United States, 62902 | |
SIH Cancer Institute | Suspended |
Carterville, Illinois, United States, 62918 | |
Illinois CancerCare-Carthage | Suspended |
Carthage, Illinois, United States, 62321 | |
Centralia Oncology Clinic | Suspended |
Centralia, Illinois, United States, 62801 | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Akhil Chawla | |
John H Stroger Jr Hospital of Cook County | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-864-5204 | |
Principal Investigator: Thomas E. Lad | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Yolande Chen | |
University of Chicago Comprehensive Cancer Center | Active, not recruiting |
Chicago, Illinois, United States, 60637 | |
Carle at The Riverfront | Suspended |
Danville, Illinois, United States, 61832 | |
Cancer Care Specialists of Illinois - Decatur | Suspended |
Decatur, Illinois, United States, 62526 | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Kishwaukee | Recruiting |
DeKalb, Illinois, United States, 60115 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Akhil Chawla | |
Carle Physician Group-Effingham | Suspended |
Effingham, Illinois, United States, 62401 | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Eureka | Suspended |
Eureka, Illinois, United States, 61530 | |
Illinois CancerCare-Galesburg | Suspended |
Galesburg, Illinois, United States, 61401 | |
Western Illinois Cancer Treatment Center | Suspended |
Galesburg, Illinois, United States, 61401 | |
Northwestern Medicine Cancer Center Delnor | Recruiting |
Geneva, Illinois, United States, 60134 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Akhil Chawla | |
Illinois CancerCare-Kewanee Clinic | Suspended |
Kewanee, Illinois, United States, 61443 | |
Illinois CancerCare-Macomb | Suspended |
Macomb, Illinois, United States, 61455 | |
Carle Physician Group-Mattoon/Charleston | Suspended |
Mattoon, Illinois, United States, 61938 | |
Loyola University Medical Center | Recruiting |
Maywood, Illinois, United States, 60153 | |
Contact: Site Public Contact 708-226-4357 | |
Principal Investigator: Asha R. Dhanarajan | |
Good Samaritan Regional Health Center | Suspended |
Mount Vernon, Illinois, United States, 62864 | |
Cancer Care Center of O'Fallon | Suspended |
O'Fallon, Illinois, United States, 62269 | |
Northwestern Medicine Orland Park | Recruiting |
Orland Park, Illinois, United States, 60462 | |
Contact: Site Public Contact nctnprogram_rhlccc@northwestern.edu | |
Principal Investigator: Akhil Chawla | |
University of Chicago Medicine-Orland Park | Active, not recruiting |
Orland Park, Illinois, United States, 60462 | |
Illinois CancerCare-Ottawa Clinic | Suspended |
Ottawa, Illinois, United States, 61350 | |
Illinois CancerCare-Pekin | Suspended |
Pekin, Illinois, United States, 61554 | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Methodist Medical Center of Illinois | Recruiting |
Peoria, Illinois, United States, 61636 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Suspended |
Peru, Illinois, United States, 61354 | |
Valley Radiation Oncology | Suspended |
Peru, Illinois, United States, 61354 | |
Illinois CancerCare-Princeton | Suspended |
Princeton, Illinois, United States, 61356 | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-528-7541 pallante.beth@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Carle Cancer Center | Suspended |
Urbana, Illinois, United States, 61801 | |
The Carle Foundation Hospital | Suspended |
Urbana, Illinois, United States, 61801 | |
Northwestern Medicine Cancer Center Warrenville | Recruiting |
Warrenville, Illinois, United States, 60555 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Akhil Chawla | |
United States, Indiana | |
Memorial Hospital of South Bend | Suspended |
South Bend, Indiana, United States, 46601 | |
United States, Iowa | |
Mary Greeley Medical Center | Suspended |
Ames, Iowa, United States, 50010 | |
McFarland Clinic - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Joseph J. Merchant | |
Mission Cancer and Blood - Ankeny | Recruiting |
Ankeny, Iowa, United States, 50023 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Joshua Lukenbill | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-3305 | |
Principal Investigator: Joshua Lukenbill | |
Broadlawns Medical Center | Active, not recruiting |
Des Moines, Iowa, United States, 50314 | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-358-6613 cancerresearch@mercydesmoines.org | |
Principal Investigator: Richard L. Deming | |
Iowa Lutheran Hospital | Active, not recruiting |
Des Moines, Iowa, United States, 50316 | |
University of Iowa/Holden Comprehensive Cancer Center | Active, not recruiting |
Iowa City, Iowa, United States, 52242 | |
Methodist West Hospital | Active, not recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
United States, Kentucky | |
Baptist Health Lexington | Active, not recruiting |
Lexington, Kentucky, United States, 40503 | |
University of Kentucky/Markey Cancer Center | Recruiting |
Lexington, Kentucky, United States, 40536 | |
Contact: Site Public Contact 859-257-3379 | |
Principal Investigator: Michael J. Cavnar | |
The James Graham Brown Cancer Center at University of Louisville | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Site Public Contact 502-562-3429 | |
Principal Investigator: Vivek R. Sharma | |
Baptist Health Louisville | Active, not recruiting |
Louisville, Kentucky, United States, 40207 | |
Baptist Health Madisonville/Merle Mahr Cancer Center | Active, not recruiting |
Madisonville, Kentucky, United States, 42431 | |
United States, Louisiana | |
LSU Health Baton Rouge-North Clinic | Recruiting |
Baton Rouge, Louisiana, United States, 70805 | |
Contact: Site Public Contact 225-765-7659 research@ololrmc.com | |
Principal Investigator: Marshall P. Stagg | |
Louisiana Hematology Oncology Associates LLC | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: Victor T. Lin | |
Mary Bird Perkins Cancer Center | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: Victor T. Lin | |
Our Lady of the Lake Physicians Group - Medical Oncology | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-765-7659 research@ololrmc.com | |
Principal Investigator: Marshall P. Stagg | |
Medical Center of Baton Rouge | Recruiting |
Baton Rouge, Louisiana, United States, 70816 | |
Contact: Site Public Contact 225-761-5346 Camille.Beck@Ochsner.org | |
Principal Investigator: Jonathan D. Mizrahi | |
Ochsner High Grove | Recruiting |
Baton Rouge, Louisiana, United States, 70836 | |
Contact: Site Public Contact 225-761-5346 Camielle.beck@ochsner.org | |
Principal Investigator: Jonathan D. Mizrahi | |
Northshore Oncology Associates-Covington | Recruiting |
Covington, Louisiana, United States, 70433 | |
Contact: Site Public Contact 225-215-1353 clinicalresearch@marybird.com | |
Principal Investigator: Victor T. Lin | |
Ochsner Hematology Oncology North Shore - Covington (West Region) | Recruiting |
Covington, Louisiana, United States, 70433 | |
Contact: Site Public Contact 985-809-5668 Cheryl.kesler@ochsner.org | |
Principal Investigator: Jonathan D. Mizrahi | |
Terrebonne General Medical Center | Recruiting |
Houma, Louisiana, United States, 70360 | |
Contact: Site Public Contact 985-850-6300 ann.hooks@tgmc.com | |
Principal Investigator: Victor T. Lin | |
Ochsner Medical Center Kenner | Recruiting |
Kenner, Louisiana, United States, 70065 | |
Contact: Site Public Contact 504-464-8789 awendt@ochsner.org | |
Principal Investigator: Jonathan D. Mizrahi | |
University Medical Center New Orleans | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-210-3539 emede1@lsuhsc.edu | |
Principal Investigator: Omeed Moaven | |
Ochsner Medical Center Jefferson | Recruiting |
New Orleans, Louisiana, United States, 70121 | |
Contact: Site Public Contact 504-842-8084 Elisemarie.curry@ochsner.org | |
Principal Investigator: Jonathan D. Mizrahi | |
United States, Maryland | |
Greater Baltimore Medical Center | Recruiting |
Baltimore, Maryland, United States, 21204 | |
Contact: Site Public Contact 443-849-3706 | |
Principal Investigator: Zhuoyan Li | |
UM Saint Joseph Medical Center | Active, not recruiting |
Towson, Maryland, United States, 21204 | |
United States, Massachusetts | |
Tufts Medical Center | Recruiting |
Boston, Massachusetts, United States, 02111 | |
Contact: Site Public Contact 617-636-5000 ContactUsCancerCenter@TuftsMedicalCenter.org | |
Principal Investigator: Jacob M. Elkon | |
Massachusetts General Hospital Cancer Center | Active, not recruiting |
Boston, Massachusetts, United States, 02114 | |
Boston Medical Center | Recruiting |
Boston, Massachusetts, United States, 02118 | |
Contact: Site Public Contact 617-638-8265 | |
Principal Investigator: Teviah Sachs | |
Dana-Farber Cancer Institute | Recruiting |
Boston, Massachusetts, United States, 02215 | |
Contact: Site Public Contact 877-442-3324 | |
Principal Investigator: Thomas E. Clancy | |
United States, Michigan | |
Hickman Cancer Center | Suspended |
Adrian, Michigan, United States, 49221 | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
University of Michigan Comprehensive Cancer Center | Recruiting |
Ann Arbor, Michigan, United States, 48109 | |
Contact: Site Public Contact 800-865-1125 | |
Principal Investigator: Vaibhav Sahai | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-7251 MCRCwebsitecontactform@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Wayne State University/Karmanos Cancer Institute | Recruiting |
Detroit, Michigan, United States, 48201 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Mohammed N. Al Hallak | |
Henry Ford Hospital | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: David S. Kwon | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Christopher M. Reynolds | |
Weisberg Cancer Treatment Center | Recruiting |
Farmington Hills, Michigan, United States, 48334 | |
Contact: Site Public Contact 313-576-9790 ctoadmin@karmanos.org | |
Principal Investigator: Mohammed N. Al Hallak | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Ascension Providence Hospitals - Novi | Recruiting |
Novi, Michigan, United States, 48374 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Susan E. Lyons | |
William Beaumont Hospital-Royal Oak | Recruiting |
Royal Oak, Michigan, United States, 48073 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Lavanya Yohanathan | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 989-907-8411 lori.srebinski@ascension.org | |
Principal Investigator: Christopher M. Reynolds | |
Ascension Providence Hospitals - Southfield | Recruiting |
Southfield, Michigan, United States, 48075 | |
Contact: Site Public Contact 248-849-5332 karen.fife@ascension.org | |
Principal Investigator: Susan E. Lyons | |
William Beaumont Hospital - Troy | Recruiting |
Troy, Michigan, United States, 48085 | |
Contact: Site Public Contact 248-551-7695 | |
Principal Investigator: Lavanya Yohanathan | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 313-343-3166 karen.forman@ascension.org | |
Principal Investigator: Christopher M. Reynolds | |
United States, Mississippi | |
Baptist Cancer Center-Grenada | Recruiting |
Grenada, Mississippi, United States, 38901 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
Baptist Memorial Hospital and Cancer Center-Union County | Recruiting |
New Albany, Mississippi, United States, 38652 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
Baptist Memorial Hospital and Cancer Center-Oxford | Recruiting |
Oxford, Mississippi, United States, 38655 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
Baptist Memorial Hospital and Cancer Center-Desoto | Recruiting |
Southhaven, Mississippi, United States, 38671 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Suspended |
Ballwin, Missouri, United States, 63011 | |
Saint Francis Medical Center | Suspended |
Cape Girardeau, Missouri, United States, 63703 | |
Southeast Cancer Center | Suspended |
Cape Girardeau, Missouri, United States, 63703 | |
MU Health - University Hospital/Ellis Fischel Cancer Center | Active, not recruiting |
Columbia, Missouri, United States, 65212 | |
Capital Region Southwest Campus | Suspended |
Jefferson City, Missouri, United States, 65109 | |
Mercy Hospital Joplin | Suspended |
Joplin, Missouri, United States, 64804 | |
Saint Luke's Hospital of Kansas City | Active, not recruiting |
Kansas City, Missouri, United States, 64111 | |
Delbert Day Cancer Institute at PCRMC | Suspended |
Rolla, Missouri, United States, 65401 | |
Mercy Clinic-Rolla-Cancer and Hematology | Suspended |
Rolla, Missouri, United States, 65401 | |
Heartland Regional Medical Center | Suspended |
Saint Joseph, Missouri, United States, 64506 | |
Washington University School of Medicine | Active, not recruiting |
Saint Louis, Missouri, United States, 63110 | |
Mercy Hospital South | Suspended |
Saint Louis, Missouri, United States, 63128 | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Suspended |
Saint Louis, Missouri, United States, 63141 | |
Sainte Genevieve County Memorial Hospital | Suspended |
Sainte Genevieve, Missouri, United States, 63670 | |
Mercy Hospital Springfield | Suspended |
Springfield, Missouri, United States, 65804 | |
CoxHealth South Hospital | Suspended |
Springfield, Missouri, United States, 65807 | |
Missouri Baptist Sullivan Hospital | Suspended |
Sullivan, Missouri, United States, 63080 | |
BJC Outpatient Center at Sunset Hills | Suspended |
Sunset Hills, Missouri, United States, 63127 | |
United States, Montana | |
Billings Clinic Cancer Center | Active, not recruiting |
Billings, Montana, United States, 59101 | |
Bozeman Deaconess Hospital | Active, not recruiting |
Bozeman, Montana, United States, 59715 | |
Benefis Healthcare- Sletten Cancer Institute | Active, not recruiting |
Great Falls, Montana, United States, 59405 | |
Great Falls Clinic | Active, not recruiting |
Great Falls, Montana, United States, 59405 | |
Kalispell Regional Medical Center | Active, not recruiting |
Kalispell, Montana, United States, 59901 | |
Community Medical Hospital | Active, not recruiting |
Missoula, Montana, United States, 59804 | |
United States, Nebraska | |
Nebraska Methodist Hospital | Recruiting |
Omaha, Nebraska, United States, 68114 | |
Contact: Site Public Contact 402-354-5144 | |
Principal Investigator: Timothy Huyck | |
United States, Nevada | |
OptumCare Cancer Care at Charleston | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Hampshire | |
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: Kathryn C. Hourdequin | |
United States, New Jersey | |
Memorial Sloan Kettering Basking Ridge | Recruiting |
Basking Ridge, New Jersey, United States, 07920 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Cooper Hospital University Medical Center | Recruiting |
Camden, New Jersey, United States, 08103 | |
Contact: Site Public Contact 856-325-6757 | |
Principal Investigator: Jamin C. Morrison | |
Englewood Hospital and Medical Center | Recruiting |
Englewood, New Jersey, United States, 07631 | |
Contact: Site Public Contact 201-894-3456 | |
Principal Investigator: Minaxi Jhawer | |
Jersey City Medical Center | Recruiting |
Jersey City, New Jersey, United States, 07302 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Russell C. Langan | |
Monmouth Medical Center Southern Campus | Recruiting |
Lakewood, New Jersey, United States, 08701 | |
Contact: Site Public Contact 732-923-6564 mary.danish@rwjbh.org | |
Principal Investigator: Russell C. Langan | |
Saint Barnabas Medical Center | Recruiting |
Livingston, New Jersey, United States, 07039 | |
Contact: Site Public Contact 973-322-2934 joanne.loeb@rwjbh.org | |
Principal Investigator: Russell C. Langan | |
Monmouth Medical Center | Recruiting |
Long Branch, New Jersey, United States, 07740 | |
Contact: Site Public Contact 732-923-6564 mary.danish@rwjbh.org | |
Principal Investigator: Russell C. Langan | |
Memorial Sloan Kettering Monmouth | Recruiting |
Middletown, New Jersey, United States, 07748 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Memorial Sloan Kettering Bergen | Recruiting |
Montvale, New Jersey, United States, 07645 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Jersey Shore Medical Center | Recruiting |
Neptune, New Jersey, United States, 07753 | |
Contact: Site Public Contact 732-776-4240 | |
Principal Investigator: John F. Gibbs | |
Rutgers Cancer Institute of New Jersey | Recruiting |
New Brunswick, New Jersey, United States, 08903 | |
Contact: Site Public Contact 732-235-7356 | |
Principal Investigator: Russell C. Langan | |
The Valley Hospital-Luckow Pavilion | Recruiting |
Paramus, New Jersey, United States, 07652 | |
Contact: Site Public Contact 201-634-5792 | |
Principal Investigator: Kevin C. Wood | |
Valley Hospital | Recruiting |
Ridgewood, New Jersey, United States, 07450 | |
Contact: Site Public Contact 201-634-5792 cparish@valleyhealth.com | |
Principal Investigator: Kevin C. Wood | |
Holy Name Hospital | Suspended |
Teaneck, New Jersey, United States, 07666 | |
United States, New Mexico | |
University of New Mexico Cancer Center | Recruiting |
Albuquerque, New Mexico, United States, 87102 | |
Contact: Site Public Contact 505-925-0348 HSC-ClinicalTrialInfo@salud.unm.edu | |
Principal Investigator: Itzhak Nir | |
United States, New York | |
Northwell Health Imbert Cancer Center | Recruiting |
Bay Shore, New York, United States, 11706 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
South Shore University Hospital | Recruiting |
Bay Shore, New York, United States, 11706 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
Montefiore Medical Center-Einstein Campus | Active, not recruiting |
Bronx, New York, United States, 10461 | |
Montefiore Medical Center-Weiler Hospital | Active, not recruiting |
Bronx, New York, United States, 10461 | |
Montefiore Medical Center - Moses Campus | Active, not recruiting |
Bronx, New York, United States, 10467 | |
Memorial Sloan Kettering Commack | Recruiting |
Commack, New York, United States, 11725 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Cancer Institute at Saint Francis Hospital | Suspended |
East Hills, New York, United States, 11548 | |
Hematology Oncology Associates of Central New York-East Syracuse | Suspended |
East Syracuse, New York, United States, 13057 | |
Northwell Health Cancer Institute at Huntington | Recruiting |
Greenlawn, New York, United States, 11740 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
Memorial Sloan Kettering Westchester | Recruiting |
Harrison, New York, United States, 10604 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Northwell Health/Center for Advanced Medicine | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
North Shore University Hospital | Recruiting |
Manhasset, New York, United States, 11030 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
Long Island Jewish Medical Center | Recruiting |
New Hyde Park, New York, United States, 11040 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
Mount Sinai West | Suspended |
New York, New York, United States, 10019 | |
Lenox Hill Hospital | Recruiting |
New York, New York, United States, 10021 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Gary B. Deutsch | |
Mount Sinai Hospital | Recruiting |
New York, New York, United States, 10029 | |
Contact: Site Public Contact 212-824-7309 CCTO@mssm.edu | |
Principal Investigator: Sofya Pintova | |
Manhattan Eye Ear and Throat Hospital | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-434-4460 | |
Principal Investigator: Gary B. Deutsch | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Upstate Cancer Center at Oswego | Recruiting |
Oswego, New York, United States, 13126 | |
Contact: Site Public Contact 315-464-8230 McDowelE@upstate.edu | |
Principal Investigator: Rahul Seth | |
Queens Cancer Center | Recruiting |
Rego Park, New York, United States, 11374 | |
Contact: Site Public Contact 718-312-3446 | |
Principal Investigator: Gary B. Deutsch | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
Staten Island University Hospital | Recruiting |
Staten Island, New York, United States, 10305 | |
Contact: Site Public Contact 718-226-8888 | |
Principal Investigator: Gary B. Deutsch | |
Stony Brook University Medical Center | Active, not recruiting |
Stony Brook, New York, United States, 11794 | |
State University of New York Upstate Medical University | Recruiting |
Syracuse, New York, United States, 13210 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Rahul Seth | |
SUNY Upstate Medical Center-Community Campus | Recruiting |
Syracuse, New York, United States, 13215 | |
Contact: Site Public Contact 315-464-5476 | |
Principal Investigator: Rahul Seth | |
Memorial Sloan Kettering Nassau | Recruiting |
Uniondale, New York, United States, 11553 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Anna M. Varghese | |
Upstate Cancer Center at Verona | Recruiting |
Verona, New York, United States, 13478 | |
Contact: Site Public Contact 315-464-8230 McDowelE@upstate.edu | |
Principal Investigator: Rahul Seth | |
Wilmot Cancer Institute at Webster | Recruiting |
Webster, New York, United States, 14580 | |
Contact: Site Public Contact WCICTOresearch@urmc.rochester.edu | |
Principal Investigator: Paul M. Barr | |
Dickstein Cancer Treatment Center | Recruiting |
White Plains, New York, United States, 10601 | |
Contact: Site Public Contact 914-849-7582 mcortese@wphospital.org | |
Principal Investigator: Dan Costin | |
United States, North Carolina | |
Carolinas Medical Center/Levine Cancer Institute | Recruiting |
Charlotte, North Carolina, United States, 28203 | |
Contact: Site Public Contact 800-804-9376 | |
Principal Investigator: Kunal C. Kadakia | |
Duke University Medical Center | Terminated |
Durham, North Carolina, United States, 27710 | |
East Carolina University | Recruiting |
Greenville, North Carolina, United States, 27834 | |
Contact: Site Public Contact 252-744-1015 eubankss@ecu.edu | |
Principal Investigator: Emmanuel E. Zervos | |
Vidant Oncology-Kinston | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Site Public Contact 252-559-2201 research@ecuhealth.org | |
Principal Investigator: Misbah U. Qadir | |
CarolinaEast Medical Center | Recruiting |
New Bern, North Carolina, United States, 28561 | |
Contact: Site Public Contact 252-634-6589 lharrison@carolinaeasthealth.com | |
Principal Investigator: Richard F. Gorman | |
Duke Women's Cancer Care Raleigh | Recruiting |
Raleigh, North Carolina, United States, 27607 | |
Contact: Site Public Contact 919-785-4878 | |
Principal Investigator: Jeffrey Crawford | |
Duke Raleigh Hospital | Terminated |
Raleigh, North Carolina, United States, 27609 | |
Wake Forest University Health Sciences | Recruiting |
Winston-Salem, North Carolina, United States, 27157 | |
Contact: Site Public Contact 336-713-6771 | |
Principal Investigator: Clancy J. Clark | |
United States, North Dakota | |
Sanford Broadway Medical Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
Sanford Roger Maris Cancer Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
United States, Ohio | |
Cleveland Clinic Akron General | Recruiting |
Akron, Ohio, United States, 44307 | |
Contact: Site Public Contact 866-223-8100 CancerAnswer@ccf.org | |
Principal Investigator: Judy Peih-Ying Tsai | |
Adena Regional Medical Center | Suspended |
Chillicothe, Ohio, United States, 45601 | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: David L. Bajor | |
MetroHealth Medical Center | Recruiting |
Cleveland, Ohio, United States, 44109 | |
Contact: Site Public Contact 216-778-7559 ababal@metrohealth.org | |
Principal Investigator: William Tse | |
Cleveland Clinic Cancer Center/Fairview Hospital | Active, not recruiting |
Cleveland, Ohio, United States, 44111 | |
Cleveland Clinic Foundation | Recruiting |
Cleveland, Ohio, United States, 44195 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Alok A. Khorana | |
Ohio State University Comprehensive Cancer Center | Active, not recruiting |
Columbus, Ohio, United States, 43210 | |
Mount Carmel East Hospital | Recruiting |
Columbus, Ohio, United States, 43213 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Riverside Methodist Hospital | Suspended |
Columbus, Ohio, United States, 43214 | |
Grant Medical Center | Suspended |
Columbus, Ohio, United States, 43215 | |
The Mark H Zangmeister Center | Recruiting |
Columbus, Ohio, United States, 43219 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Mount Carmel Health Center West | Suspended |
Columbus, Ohio, United States, 43222 | |
Doctors Hospital | Suspended |
Columbus, Ohio, United States, 43228 | |
Miami Valley Hospital | Recruiting |
Dayton, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Tarek M. Sabagh | |
Dublin Methodist Hospital | Suspended |
Dublin, Ohio, United States, 43016 | |
Mount Carmel Grove City Hospital | Recruiting |
Grove City, Ohio, United States, 43123 | |
Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
OhioHealth Mansfield Hospital | Suspended |
Mansfield, Ohio, United States, 44903 | |
Cleveland Clinic Cancer Center Mansfield | Active, not recruiting |
Mansfield, Ohio, United States, 44906 | |
Marietta Memorial Hospital | Suspended |
Marietta, Ohio, United States, 45750 | |
Hillcrest Hospital Cancer Center | Active, not recruiting |
Mayfield Heights, Ohio, United States, 44124 | |
Licking Memorial Hospital | Suspended |
Newark, Ohio, United States, 43055 | |
Newark Radiation Oncology | Suspended |
Newark, Ohio, United States, 43055 | |
Southern Ohio Medical Center | Suspended |
Portsmouth, Ohio, United States, 45662 | |
North Coast Cancer Care | Active, not recruiting |
Sandusky, Ohio, United States, 44870 | |
University of Toledo | Recruiting |
Toledo, Ohio, United States, 43614 | |
Contact: Site Public Contact 419-383-6583 | |
Principal Investigator: Ahmad Zarzour | |
Toledo Clinic Cancer Centers-Toledo | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
Saint Ann's Hospital | Recruiting |
Westerville, Ohio, United States, 43081 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Cleveland Clinic Wooster Family Health and Surgery Center | Active, not recruiting |
Wooster, Ohio, United States, 44691 | |
Genesis Healthcare System Cancer Care Center | Suspended |
Zanesville, Ohio, United States, 43701 | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Hassan Hatoum | |
Mercy Hospital Oklahoma City | Suspended |
Oklahoma City, Oklahoma, United States, 73120 | |
United States, Oregon | |
Saint Charles Health System | Suspended |
Bend, Oregon, United States, 97701 | |
Clackamas Radiation Oncology Center | Suspended |
Clackamas, Oregon, United States, 97015 | |
Providence Cancer Institute Clackamas Clinic | Suspended |
Clackamas, Oregon, United States, 97015 | |
Bay Area Hospital | Suspended |
Coos Bay, Oregon, United States, 97420 | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Willamette Falls Medical Center | Recruiting |
Oregon City, Oregon, United States, 97045 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Kaiser Permanente Northwest | Active, not recruiting |
Portland, Oregon, United States, 97227 | |
United States, Pennsylvania | |
Jefferson Abington Hospital | Not yet recruiting |
Abington, Pennsylvania, United States, 19001 | |
Contact: Steven J. Cohen steven.cohen@jefferson.edu | |
Principal Investigator: Steven J. Cohen | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 610-402-9543 Morgan_M.Horton@lvhn.org | |
Principal Investigator: Christopher M. Reynolds | |
Ephrata Cancer Center | Recruiting |
Ephrata, Pennsylvania, United States, 17522 | |
Contact: Site Public Contact 717-721-4840 | |
Principal Investigator: Dan Sotirescu | |
Saint Vincent Hospital | Active, not recruiting |
Erie, Pennsylvania, United States, 16544 | |
Adams Cancer Center | Recruiting |
Gettysburg, Pennsylvania, United States, 17325 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Dan Sotirescu | |
Jefferson Hospital | Active, not recruiting |
Jefferson Hills, Pennsylvania, United States, 15025 | |
Sechler Family Cancer Center | Recruiting |
Lebanon, Pennsylvania, United States, 17042 | |
Contact: Site Public Contact 717-741-8303 doxenberg@wellspan.org | |
Principal Investigator: Dan Sotirescu | |
Forbes Hospital | Active, not recruiting |
Monroeville, Pennsylvania, United States, 15146 | |
Thomas Jefferson University Hospital | Active, not recruiting |
Philadelphia, Pennsylvania, United States, 19107 | |
Allegheny General Hospital | Active, not recruiting |
Pittsburgh, Pennsylvania, United States, 15212 | |
West Penn Hospital | Active, not recruiting |
Pittsburgh, Pennsylvania, United States, 15224 | |
Guthrie Medical Group PC-Robert Packer Hospital | Recruiting |
Sayre, Pennsylvania, United States, 18840 | |
Contact: Site Public Contact 800-836-0388 | |
Principal Investigator: Joyson Poulose | |
Reading Hospital | Recruiting |
West Reading, Pennsylvania, United States, 19611 | |
Contact: Site Public Contact 610-988-9323 | |
Principal Investigator: Terrence P. Cescon | |
Wexford Health and Wellness Pavilion | Active, not recruiting |
Wexford, Pennsylvania, United States, 15090 | |
Asplundh Cancer Pavilion | Recruiting |
Willow Grove, Pennsylvania, United States, 19090 | |
Contact: Site Public Contact 215-600-9151 ONCTrialNow@jefferson.edu | |
Principal Investigator: Steven J. Cohen | |
WellSpan Health-York Cancer Center | Recruiting |
York, Pennsylvania, United States, 17403 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Dan Sotirescu | |
WellSpan Health-York Hospital | Recruiting |
York, Pennsylvania, United States, 17403 | |
Contact: Site Public Contact 877-441-7957 | |
Principal Investigator: Dan Sotirescu | |
United States, Rhode Island | |
Smilow Cancer Hospital Care Center - Westerly | Recruiting |
Westerly, Rhode Island, United States, 02891 | |
Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu | |
Principal Investigator: John W. Kunstman | |
United States, South Carolina | |
Ralph H Johnson VA Medical Center | Recruiting |
Charleston, South Carolina, United States, 29401 | |
Contact: Site Public Contact 843-789-7020 ashley.salvo@va.gov | |
Principal Investigator: Oleksandra Lupak | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Site Public Contact 843-792-9321 hcc-clinical-trials@musc.edu | |
Principal Investigator: Katherine Morgan | |
Prisma Health Cancer Institute - Faris | Recruiting |
Greenville, South Carolina, United States, 29605 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Eastside | Recruiting |
Greenville, South Carolina, United States, 29615 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Greer | Recruiting |
Greer, South Carolina, United States, 29650 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
Prisma Health Cancer Institute - Seneca | Recruiting |
Seneca, South Carolina, United States, 29672 | |
Contact: Site Public Contact 864-241-6251 | |
Principal Investigator: Ki Y. Chung | |
United States, South Dakota | |
Sanford Cancer Center Oncology Clinic | Recruiting |
Sioux Falls, South Dakota, United States, 57104 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicTrialsSF@sanfordhealth.org | |
Principal Investigator: Daniel Almquist | |
Sanford USD Medical Center - Sioux Falls | Recruiting |
Sioux Falls, South Dakota, United States, 57117-5134 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicalTrialsSF@SanfordHealth.org | |
Principal Investigator: Daniel Almquist | |
United States, Tennessee | |
Baptist Memorial Hospital and Cancer Center-Collierville | Recruiting |
Collierville, Tennessee, United States, 38017 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
University of Tennessee - Knoxville | Recruiting |
Knoxville, Tennessee, United States, 37920 | |
Contact: Site Public Contact 865-544-9773 | |
Principal Investigator: Ryan K. Schmocker | |
Baptist Memorial Hospital and Cancer Center-Memphis | Recruiting |
Memphis, Tennessee, United States, 38120 | |
Contact: Site Public Contact 901-226-1366 BCCclintrials@bmhcc.org | |
Principal Investigator: Stephen W. Behrman | |
United States, Texas | |
The Don and Sybil Harrington Cancer Center | Recruiting |
Amarillo, Texas, United States, 79106 | |
Contact: Site Public Contact 806-212-1985 Gina.Cravey@bsahs.org | |
Principal Investigator: Anita Ravipati | |
UT Southwestern/Simmons Cancer Center-Dallas | Recruiting |
Dallas, Texas, United States, 75390 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Patricio M. Polanco | |
UT Southwestern/Simmons Cancer Center-Fort Worth | Recruiting |
Fort Worth, Texas, United States, 76104 | |
Contact: Site Public Contact 214-648-7097 canceranswerline@UTSouthwestern.edu | |
Principal Investigator: Patricio M. Polanco | |
UT Southwestern Clinical Center at Richardson/Plano | Recruiting |
Richardson, Texas, United States, 75080 | |
Contact: Site Public Contact 972-669-7044 Suzanne.cole@utsouthwestern.edu | |
Principal Investigator: Patricio M. Polanco | |
University of Texas Health Science Center at San Antonio | Active, not recruiting |
San Antonio, Texas, United States, 78229 | |
United States, Vermont | |
University of Vermont Medical Center | Active, not recruiting |
Burlington, Vermont, United States, 05401 | |
United States, Virginia | |
Inova Schar Cancer Institute | Recruiting |
Fairfax, Virginia, United States, 22031 | |
Contact: Site Public Contact 703-720-5210 Stephanie.VanBebber@inova.org | |
Principal Investigator: Raymond C. Wadlow | |
Inova Fairfax Hospital | Recruiting |
Falls Church, Virginia, United States, 22042 | |
Contact: Site Public Contact 703-208-6650 Stephanie.VanBebber@inova.org | |
Principal Investigator: Raymond C. Wadlow | |
Sentara Leigh Hospital | Recruiting |
Norfolk, Virginia, United States, 23502 | |
Contact: Site Public Contact 757-388-5109 djoverto@sentara.com | |
Principal Investigator: Marybeth S. Hughes | |
Sentara Norfolk General Hospital | Recruiting |
Norfolk, Virginia, United States, 23507 | |
Contact: Site Public Contact 757-388-2406 | |
Principal Investigator: Marybeth S. Hughes | |
Virginia Commonwealth University/Massey Cancer Center | Recruiting |
Richmond, Virginia, United States, 23298 | |
Contact: Site Public Contact CTOclinops@vcu.edu | |
Principal Investigator: Leopoldo J. Fernandez | |
VCU Community Memorial Health Center | Recruiting |
South Hill, Virginia, United States, 23970 | |
Contact: Site Public Contact nemer.elmouallem@vcuhealth.org | |
Principal Investigator: Leopoldo J. Fernandez | |
United States, Washington | |
Providence Regional Cancer System-Aberdeen | Suspended |
Aberdeen, Washington, United States, 98520 | |
Overlake Medical Center | Suspended |
Bellevue, Washington, United States, 98004 | |
PeaceHealth Saint Joseph Medical Center | Suspended |
Bellingham, Washington, United States, 98225 | |
Providence Regional Cancer System-Centralia | Suspended |
Centralia, Washington, United States, 98531 | |
Swedish Cancer Institute-Edmonds | Suspended |
Edmonds, Washington, United States, 98026 | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Issaquah | Suspended |
Issaquah, Washington, United States, 98029 | |
Providence Regional Cancer System-Lacey | Suspended |
Lacey, Washington, United States, 98503 | |
PeaceHealth Saint John Medical Center | Suspended |
Longview, Washington, United States, 98632 | |
Swedish Medical Center-Ballard Campus | Suspended |
Seattle, Washington, United States, 98107 | |
FHCC South Lake Union | Recruiting |
Seattle, Washington, United States, 98109 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Andrew L. Coveler | |
Fred Hutchinson Cancer Research Center | Recruiting |
Seattle, Washington, United States, 98109 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Andrew L. Coveler | |
Swedish Medical Center-First Hill | Suspended |
Seattle, Washington, United States, 98122 | |
University of Washington Medical Center - Montlake | Recruiting |
Seattle, Washington, United States, 98195 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Andrew L. Coveler | |
PeaceHealth United General Medical Center | Suspended |
Sedro-Woolley, Washington, United States, 98284 | |
PeaceHealth Southwest Medical Center | Suspended |
Vancouver, Washington, United States, 98664 | |
Providence Saint Mary Regional Cancer Center | Suspended |
Walla Walla, Washington, United States, 99362 | |
United States, West Virginia | |
West Virginia University Charleston Division | Recruiting |
Charleston, West Virginia, United States, 25304 | |
Contact: Site Public Contact 304-388-9944 | |
Principal Investigator: Ahmed A. Khalid | |
United States, Wisconsin | |
Langlade Hospital and Cancer Center | Suspended |
Antigo, Wisconsin, United States, 54409 | |
Marshfield Medical Center-EC Cancer Center | Recruiting |
Eau Claire, Wisconsin, United States, 54701 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Gundersen Lutheran Medical Center | Recruiting |
La Crosse, Wisconsin, United States, 54601 | |
Contact: Site Public Contact 608-775-2385 cancerctr@gundersenhealth.org | |
Principal Investigator: Michael O. Ojelabi | |
Marshfield Medical Center-Marshfield | Recruiting |
Marshfield, Wisconsin, United States, 54449 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aspirus Medford Hospital | Suspended |
Medford, Wisconsin, United States, 54451 | |
Ascension Columbia Saint Mary's Hospital Ozaukee | Recruiting |
Mequon, Wisconsin, United States, 53097 | |
Contact: Site Public Contact AWRI.Inquiry@Ascension.org | |
Principal Investigator: Ranveer Nand | |
Ascension Columbia Saint Mary's Hospital - Milwaukee | Recruiting |
Milwaukee, Wisconsin, United States, 53211 | |
Contact: Site Public Contact AWRI.Inquiry@Ascension.org | |
Principal Investigator: Ranveer Nand | |
Marshfield Clinic-Minocqua Center | Recruiting |
Minocqua, Wisconsin, United States, 54548 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Marshfield Medical Center-Rice Lake | Recruiting |
Rice Lake, Wisconsin, United States, 54868 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Marshfield Medical Center-River Region at Stevens Point | Recruiting |
Stevens Point, Wisconsin, United States, 54482 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aspirus Regional Cancer Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 877-405-6866 | |
Principal Investigator: Andrew J. Huang | |
Marshfield Medical Center - Weston | Recruiting |
Weston, Wisconsin, United States, 54476 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Seth O. Fagbemi | |
Aspirus Cancer Care - Wisconsin Rapids | Suspended |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
United States, Wyoming | |
Welch Cancer Center | Active, not recruiting |
Sheridan, Wyoming, United States, 82801 | |
Canada, Alberta | |
Tom Baker Cancer Centre | Recruiting |
Calgary, Alberta, Canada, T2N 4N2 | |
Contact: Site Public Contact 403-521-3433 | |
Principal Investigator: Patricia Tang | |
Canada, British Columbia | |
BCCA-Vancouver Cancer Centre | Recruiting |
Vancouver, British Columbia, Canada, V5Z 4E6 | |
Contact: Site Public Contact 888-939-3333 | |
Principal Investigator: Daniel J. Renouf | |
BCCA-Vancouver Island Cancer Centre | Recruiting |
Victoria, British Columbia, Canada, V8R 6V5 | |
Contact: Site Public Contact 604-877-6010 | |
Principal Investigator: Nicholas A. Bosma | |
Canada, Manitoba | |
CancerCare Manitoba | Recruiting |
Winnipeg, Manitoba, Canada, R3E 0V9 | |
Contact: Site Public Contact 866-561-1026 ctu_web@cancercare.mb.ca | |
Principal Investigator: Christina Kim | |
Canada, Nova Scotia | |
QEII Health Sciences Centre/Nova Scotia Health Authority | Recruiting |
Halifax, Nova Scotia, Canada, B3H 2Y9 | |
Contact: Site Public Contact 902-473-6000 | |
Principal Investigator: Ravi A. Ramjeesingh | |
Canada, Ontario | |
Juravinski Cancer Centre at Hamilton Health Sciences | Recruiting |
Hamilton, Ontario, Canada, L8V 5C2 | |
Contact: Site Public Contact 905-387-9495 | |
Principal Investigator: Pablo E. Serrano | |
Ottawa Hospital and Cancer Center-General Campus | Recruiting |
Ottawa, Ontario, Canada, K1H 8L6 | |
Contact: Site Public Contact 613-761-4395 | |
Principal Investigator: Guillaume Martel | |
Odette Cancer Centre- Sunnybrook Health Sciences Centre | Recruiting |
Toronto, Ontario, Canada, M4N 3M5 | |
Contact: Site Public Contact 416-480-5000 | |
Principal Investigator: Michael J. Raphael | |
Canada, Quebec | |
The Research Institute of the McGill University Health Centre (MUHC) | Recruiting |
Montreal, Quebec, Canada, H3H 2R9 | |
Contact: Site Public Contact 514-934-1934 ext 48354 evelyn.ortega@muhc.mcgill.ca | |
Principal Investigator: George Zogopoulos | |
CHU de Quebec-L'Hotel-Dieu de Quebec (HDQ) | Recruiting |
Quebec City, Quebec, Canada, G1R 2J6 | |
Contact: Site Public Contact rechclinique@crchuq.ulaval.ca | |
Principal Investigator: Jean-Francois Ouellet | |
Centre Hospitalier Universitaire de Sherbrooke-Fleurimont | Recruiting |
Sherbrooke, Quebec, Canada, J1H 5N4 | |
Contact: Site Public Contact 819-820-6480 crcinformation.chus@ssss.gouv.qc.ca | |
Principal Investigator: Frederic Lemay |
Study Chair: | Cristina R. Ferrone, MD | Massachusetts General Hospital |
Responsible Party: | Alliance for Clinical Trials in Oncology |
ClinicalTrials.gov Identifier: | NCT04340141 |
Other Study ID Numbers: |
A021806 NCI-2020-01560 ( Registry Identifier: NCI Clinical Trial Reporting Program ) U10CA180821 ( U.S. NIH Grant/Contract ) |
First Posted: | April 9, 2020 Key Record Dates |
Last Update Posted: | April 9, 2024 |
Last Verified: | April 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | Yes |
Pancreatic Neoplasms Carcinoma, Adenosquamous Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Digestive System Neoplasms Neoplasms by Site Endocrine Gland Neoplasms Digestive System Diseases Pancreatic Diseases Endocrine System Diseases Neoplasms, Complex and Mixed Leucovorin Fluorouracil |
Oxaliplatin Irinotecan Calcium Levoleucovorin Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Antimetabolites Molecular Mechanisms of Pharmacological Action Antimetabolites, Antineoplastic Antineoplastic Agents Immunosuppressive Agents Immunologic Factors Topoisomerase I Inhibitors Topoisomerase Inhibitors Enzyme Inhibitors |